ReutersReuters

Neurosense Announces Third Quarter 2022 Financial Results And Provides Business Update

Neurosense Therapeutics Ltd NRSN:

  • NEUROSENSE THERAPEUTICS LTD - 9-MONTH LOSS PER SHARE $0.80

  • NEUROSENSE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

  • NEUROSENSE THERAPEUTICS LTD - AS OF SEPTEMBER 30, 2022, NEUROSENSE HAD CASH AND SHORT-TERM DEPOSITS OF $8.44 MILLION

  • NEUROSENSE THERAPEUTICS LTD - BELIEVES THAT CASH RESOURCES WILL BE SUFFICIENT TO CONTINUE DEVELOPMENT OF CO'S PRODUCT INTO Q4 OF 2023

Sertai secara percuma untuk mengetahui keseluruhan cerita
News unlock banner